Prostate cancer screening and informed decision-making: provider and patient perspectives

Area of Science:

• Urology
• Public Health
• Health Services Research

Background:

• Prostate cancer screening involves complex decisions regarding benefits and risks.
• Current guidelines emphasize informed decision-making over universal screening.
• Understanding screening practices and patient-provider discussions is crucial.

Purpose of the Study:

• To assess the level of informed decision-making for prostate cancer screening in Washington state.
• To examine prostate cancer screening rates among men aged 50 and above.
• To evaluate primary care physicians' screening practices and patient communication.

Main Methods:

• A population-based survey of men aged 50+ (BRFSS, 2004, Washington state).
• A simple random sample survey of primary care physicians in the same region.
• Analysis of screening rates and physician discussion of screening benefits, risks, and treatment side effects.

Main Results:

• Prostate cancer screening rates were 56% (50-64), 68% (65-79), and 64% (80+).
• Physician discussions of PSA testing benefits/risks (74%) and treatment side effects (35%) were limited; educational tools were rarely used.
• Factors associated with screening included age, income, insurance, and discussing screening with a provider.

Conclusions:

• Prostate cancer screening rates are high, potentially exceeding informed decision-making levels.
• Physicians frequently recommend screening but often fail to fully discuss all relevant information.
• There is a significant need to improve informed decision-making processes for prostate cancer screening.